Ftse Mib
34.249,77
0,91%
DAX
18.161,01
1,32%
S&P 500
5.099,96
1,02%
NASDAQ Composite
15.927,90
2,03%
Bitcoin
63.785,32
0,58%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Assistenza
Home Investire Azioni U.S.A. AMEX Palatin Technologies Inc New (PTN) Palatin Technologies Inc New (PTN) Notizie

Palatin Technologies Inc New

PTN
1,827
0,107 (6,22%)
27 Apr 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: AMEX
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
08/4/202413:30PRNUSPalatin Announces Phase 3 PL9643 MELODY-1 Dry Eye Disease..
07/3/202423:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202418:57EDGAR2Form 144 - Report of proposed sale of securities
28/2/202413:30PRNUSPalatin Announces Results of PL9643 MELODY-1 Pivotal Phase 3..
15/2/202415:00EDGAR2Form 8-K - Current report
15/2/202413:30PRNUSPalatin Reports Second Quarter Fiscal Year 2024 Financial..
14/2/202422:17EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/2/202420:55EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09/2/202413:30PRNUSPalatin to Report Second Quarter Fiscal Year 2024 Results;..
05/2/202413:30PRNUSPalatin Announces Database Lock for PL9643 MELODY-1 Pivotal..
01/2/202423:16EDGAR2Form 8-K - Current report
01/2/202422:00PRNUSPalatin Announces Closing of $10 Million Registered Direct..
30/1/202414:00PRNUSPalatin Announces $10 Million Registered Direct Offering
08/1/202416:33PRNUSPalatin Provides Corporate Update and Highlights Strategic..
03/1/202414:00BWCosette Pharmaceuticals Acquires Vyleesi® (Bremelanotide..
20/12/202315:00EDGAR2Form 8-K - Current report
20/12/202313:30PRNUSPalatin Completes Sale of Vyleesi® to Cosette..
18/12/202322:45EDGAR2Form 8-K - Current report
18/12/202322:15PRNUSPalatin Receives Notice of Acceptance of the Listing..
18/12/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
08/12/202323:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202323:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202320:25EDGAR2Form 144 - Report of proposed sale of securities
04/12/202323:00EDGAR2Form S-1 - General form for registration of securities under..
01/12/202321:52EDGAR2Form 144 - Report of proposed sale of securities
14/11/202313:30PRNUSPalatin Reports First Quarter Fiscal Year 2024 Financial..
09/11/202313:30PRNUSPalatin to Report First Quarter Fiscal Year 2024 Results;..
24/10/202322:50PRNUSPalatin Announces Closing of $5 Million Registered Direct..
24/10/202322:05EDGAR2Form 8-K - Current report
23/10/202313:30PRNUSPalatin Announces $5 Million Registered Direct Offering
19/10/202314:01EDGAR2Form 8-K - Current report
19/10/202313:30PRNUSPalatin Announces Preliminary Quarter Ended September 30,..
18/10/202313:30PRNUSPalatin Announces Positive Preclinical Data Showing..
16/10/202313:30PRNUSPalatin Presents Data at the United European..
13/10/202322:31EDGAR2Form 8-K - Current report
13/10/202322:15PRNUSPalatin Receives Notice of Non-Compliance from NYSE American
28/9/202314:02EDGAR2Form 8-K - Current report
28/9/202314:00EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
28/9/202313:30PRNUSPalatin Reports Fourth Quarter and Fiscal Year Ended 2023..
22/9/202322:00PRNUSPalatin to Report Fourth Quarter and Fiscal Year End 2023..
08/9/202314:00EDGAR2Form 8-K - Current report
07/9/202322:00PRNUSPalatin to Present at the H.C. Wainwright 25th Annual Global..
07/9/202314:49EDGAR2Form 8-K - Current report
07/9/202313:30PRNUSPalatin Completes Enrollment in Phase 3 MELODY-1 Study of..
17/8/202303:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/8/202303:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202314:15EDGAR2Form 8-K - Current report
10/8/202313:30PRNUSPalatin Initiates Clinical Program for Bremelanotide..
08/8/202314:00EDGAR2Form 8-K - Current report
08/8/202313:30PRNUSPalatin's Vyleesi® Licensee Fosun Pharma Reports First..
Apertura: 1,72 Min: 1,68 Max: 1,83
Chiusura: 1,72

La tua Cronologia

AMEX
PTN
Palatin Technologies
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network